Critical combinations of radiation dose and volume predict intelligence quotient and academic achievement scores after craniospinal irradiation in children with medulloblastoma

International Journal of Radiation Oncology Biology Physics

Volumn 90, Issue 3, 2014, Pages 554-561

  Merchant, Thomas E ^a   Schreiber, Jane E ^a   Wu, Shengjie ^a   Lukose, Renin ^a   Xiong, Xiaoping ^a   Gajjar, Amar ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; CEREBROSPINAL FLUID; CHEMOTHERAPY; ESTIMATION; FORECASTING; IRRADIATION; RADIATION EFFECTS; RISK PERCEPTION;

ACADEMIC ACHIEVEMENTS; CLINICAL TARGET VOLUME MARGINS; CRANIOSPINAL IRRADIATION; DOSE DISTRIBUTIONS; HIGH-RISK PATIENTS; INTELLIGENCE QUOTIENTS; INTENSITY MODULATED RADIATION THERAPY; METHODS AND MATERIALS;

PATIENT TREATMENT;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; ARTICLE; BRAIN SIZE; CEREBROSPINAL FLUID SHUNTING; CHILD; COGNITIVE DEFECT; CRANIOSPINAL IRRADIATION; FEMALE; HIGH RISK PATIENT; HIPPOCAMPUS; HUMAN; INTELLIGENCE QUOTIENT; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; RACE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; SEX; TEMPORAL LOBE; TREATMENT PLANNING; ADVERSE EFFECTS; BRAIN; CEREBELLAR NEOPLASMS; COMPUTER ASSISTED RADIOTHERAPY; EDUCATIONAL STATUS; INTELLIGENCE; MATHEMATICS; PRESCHOOL CHILD; PROCEDURES; PROSPECTIVE STUDY; RADIATION RESPONSE; READING; SEX DIFFERENCE; YOUNG ADULT;

ADOLESCENT; BRAIN; CEREBELLAR NEOPLASMS; CEREBROSPINAL FLUID SHUNTS; CHILD; CHILD, PRESCHOOL; CRANIOSPINAL IRRADIATION; EDUCATIONAL STATUS; FEMALE; HUMANS; INTELLIGENCE; MALE; MATHEMATICS; MEDULLOBLASTOMA; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; READING; SEX FACTORS; YOUNG ADULT;

EID: 84908003299     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.06.058     Document Type: Article

References (30)

1. C.L. Silverman, H. Palkes, and B. Talent Late effects of radiotherapy on patients with cerebellar medulloblastoma Cancer 54 1984 825 829
2. S. LeBaron, P.M. Zeltzer, and L.K. Zeltzer Assessment of quality of survival in children with medulloblastoma and cerebellar astrocytoma Cancer 62 1988 1215 1222
3. E. Hoppe-Hirsch, D. Renier, and A. Lellouch-Tubiana Medulloblastoma in childhood: Progressive intellectual deterioration Childs Nerv Syst 6 1990 60 65
4. G.D. Kao, J.W. Goldwein, and D.J. Schultz The impact of perioperative factors on subsequent intelligence quotient deficits in children treated for medulloblastoma/posterior fossa primitive neuroectodermal tumors Cancer 74 1994 965 971
5. J. Radcliffe, G.R. Bunin, and L.N. Sutton Cognitive deficits in long-term survivors of childhood medulloblastoma and other noncortical tumors: Age-dependent effects of whole brain radiation Int J Dev Neurosci 12 1994 327 334
6. R.J. Packer, J. Goldwein, and H.S. Nicholson Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study J Clin Oncol 17 1999 2127 2136
7. T.E. Merchant, L.E. Kun, and M.J. Krasin Multi-institution prospective trial of reduced-dose craniospinal radiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensitive chemotherapy for average-risk medulloblastoma Int J Radiat Oncol Biol Phys 70 2008 782 787
8. Gajjar A. A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma. NCT01878617 (SJMB03). ClinicalTrials.gov 2013. Available from: URL: http://clinicaltrials.gov/ct2/show/NCT01878617?term=sjmb03&rank=1. Accessed July 24, 2014.
9. Michalski J. A study evaluating limited target volume boost irradiation and reduced dose craniospinal radiotherapy (18.00 Gy) and chemotherapy in children with newly diagnosed standard risk medulloblastoma: A phase III double randomized Trial. ClinicalTrials.gov identifier NCT00085735 (ACNS0331). Available at: http://clinicaltrials.gov/ct2/show/NCT00085735?term=acns0331&rank=1.
10. M.D. Ris, R. Packer, and J. Goldwein Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: A Children's Cancer Group study J Clin Oncol 19 2001 3470 3476
11. A.W. Walter, R.K. Mulhern, and A. Gajjar Survival and neurodevelopmental outcome of young children with medulloblastoma at St. Jude Children's Research Hospital J Clin Oncol 17 1999 3720 3728
12. G.T. Armstrong, N. Jain, and Liu Region-specific radiotherapy and neuropsychological outcomes in adult survivors of childhood CNS malignancies Neuro Oncol 12 2010 1173 1186
13. T.E. Merchant, E.N. Kiehna, and C. Li Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma Int J Radiat Oncol Biol Phys 65 2006 210 221
14. M.L. Monje, H. Vogel, and M. Masek Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies Ann Neurol 62 2007 515 520
15. Y.R. Lawrence, and el N.I. Li XA Radiation dose-volume effects in the brain Int J Radiat Oncol Biol Phys 76 3 Suppl 2010 S20 S27
16. A. Gajjar, M. Chintagumpala, and D. Ashley Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St. Jude Medulloblastoma-96); long-term results from a prospective, multicentre trial Lancet Oncol 7 2006 813 820
17. D. Wechsler Wechsler Preschool and Primary Scale of Intelligence Revised (WPPSI-R) 1989 Psychological Corporation San Antonio, TX
18. D. Wechsler Wechsler Intelligence Scale for Children (WISC-III) 3rd ed. 1991 Psychological Corporation New York
19. D. Wechsler Wechsler Adult Intelligence Scale 1981 Psychological Corporation New York Revised (WAIS-Revised)
20. J.H. Sattler Assessment of Children 3rd ed. 1992 Jerome M. Sattler San Diego, CA 219 243
21. D. Wechsler Wechsler Individual Achievement Test 1992 Psychology Corporation New York
22. K. Edelstein, B.J. Spiegler, and S. Fung Early aging in adult survivors of childhood medulloblastoma: Long-term neurocognitive, functional, and physical outcomes Neuro Oncol 13 2011 536 545
23. M. Massimino, G. Cefalo, and D. Riva Long-term results of combined preradiation chemotherapy and age-tailored radiotherapy doses for childhood medulloblastoma J Neurooncol 108 2012 163 171
24. T. Gupta, R. Jalali, and S. Goswami Early clinical outcomes demonstrate preserved cognitive function in children with average-risk medulloblastoma when treated with hyperfractionated radiation therapy Int J Radiat Oncol Biol Phys 83 2012 1534 1540
25. Gajjar A. A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma. NCT01878617. ClinicalTrials.gov 2013. Available from: URL: http://clinicaltrials.gov/ct2/results?term=sjmb12. Accessed July 24, 2014.
26. T.E. Merchant Clinical controversies: Proton therapy for pediatric tumors Semin Radiat Oncol 23 2013 97 108
27. T.E. Merchant Proton beam therapy in pediatric oncology Cancer J 15 2009 298 305
28. R.K. Mulhern, T.E. Merchant, and A. Gajjar Late neurocognitive sequelae in survivors of brain tumours in childhood Lancet Oncol 5 2004 399 408
29. C. Di Rocco, D. Chieffo, and B.L. Pettorini Preoperative and postoperative neurological, neuropsychological and behavioral impairment in children with posterior cranial fossa astrocytomas and medulloblastomas: The role of the tumor and the impact of the surgical treatment Childs Nerv Syst 26 2010 1173 1188
30. S.L. Palmer, T. Hassall, and K. Evankovich Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma Neuro Oncol 12 2010 1311 1317